CTHRC1 and pancreatic neoplasm: Notably, HPSC‐CM exhibited significantly weaker activation of the STAT3 signaling pathway compared to CAFs‐CM, indicating that CTHRC1 in CAFs plays a critical role in activating this pathway in pancreatic cancer cells.